The DDRC has a network of CTSC hubs at UNM, KUMC and UNC in partnership with NCATS, which connects them to the CTSA consortium. This network will provide unique resources for rapidly translating existing drugs for new clinical trials. The goal of the DDRC is to develop and provide resources to translate our unique research and multisite trial strengths.
The DDRC will:
The mission of the DDRC is to improve health outcomes by rapidly identifying and providing new drugs for multisite clinical trials, as well as facilitate first-in-human studies.
DDRC will solicit collaborations through:
The timeline for translating project concepts into multisite trials is 12-24 months.
Applicants will be notified within a month after submitting their proposal whether they will be part of the project.
Lead, Drug Discovery and Repurposing Core (DDRC)
|
Cite the Grant: This project is supported by an award from the National Center for Advancing Translational Sciences, National Institutes of Health under grant number UL1TR001449. Link the Grant: To your publication in NCBI My Bibliography (Pandhi & Campen, PIs) |